1. Home
  2. DHX vs CRBP Comparison

DHX vs CRBP Comparison

Compare DHX & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$4.52

Market Cap

178.0M

ML Signal

HOLD

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.86

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
CRBP
Founded
1991
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.0M
190.3M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
DHX
CRBP
Price
$4.52
$8.86
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$6.25
$45.50
AVG Volume (30 Days)
275.9K
577.7K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$127,826,000.00
$4,822,272.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
$116.00
P/E Ratio
$43.00
N/A
Revenue Growth
N/A
97.62
52 Week Low
$1.44
$7.12
52 Week High
$4.79
$20.56

Technical Indicators

Market Signals
Indicator
DHX
CRBP
Relative Strength Index (RSI) 55.60 36.08
Support Level $3.80 $7.62
Resistance Level N/A $9.66
Average True Range (ATR) 0.29 0.70
MACD 0.01 -0.16
Stochastic Oscillator 60.80 5.66

Price Performance

Historical Comparison
DHX
CRBP

About DHX DHI Group Inc.

DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: